Vescovi P, Meleti M, Merigo E, Manfredi M, Fornaini C, Guidotti R, Nammour S. Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy. Med Oral Patol Oral Cir Bucal. 2013 Jul 1;18 (4):e680-5.  

 

 

doi:10.4317/medoral.18812

http://dx.doi.org/doi:10.4317/medoral.18812

 

 

1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-7.
http://dx.doi.org/10.1016/S0278-2391(03)00720-1

 

2. Reid IR. Osteonecrosis of the jaw: who gets it, and why?. Bone. 2009;44:4-10.
http://dx.doi.org/10.1016/j.bone.2008.09.012
PMid:18948230

 

3. Bagan JV, Jimenez Y, Diaz JM, Murillo J, Sanchis JM, Poveda R, et al. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol. 2006;42:327-9.
http://dx.doi.org/10.1016/j.oraloncology.2005.08.001
PMid:16275156

 

4. Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med. 2005;34:613-7.
http://dx.doi.org/10.1111/j.1600-0714.2005.00351.x
PMid:16202082

 

5. Marx RE, Cillo JE, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397-410.
http://dx.doi.org/10.1016/j.joms.2007.08.003
PMid:18022461

 

6. Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-61.
http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00009
PMid:16702591

 

7. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:433-41.
http://dx.doi.org/10.1016/j.tripleo.2006.06.004
PMid:16997108

 

8. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol. 2009;45:164-72.
http://dx.doi.org/10.1016/j.oraloncology.2008.04.013
PMid:18715819

 

9. Sarin J, DeRossi SS, Akintoye SO. Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis. 2008;14:277-85.
http://dx.doi.org/10.1111/j.1601-0825.2007.01381.x
PMid:18336375

 

10. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?. Bone. 2007;41:318-20.
http://dx.doi.org/10.1016/j.bone.2007.04.196
PMid:17572168

 

11. Landesberg R, Cozin M, Cremers S, Woo V, Koester S, Sinha S, et al. Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg. 2008;66:839-47.
http://dx.doi.org/10.1016/j.joms.2008.01.026
PMid:18423269 PMCid:2426967

 

12. Green JR. Bisphosphonates: preclinical review. Oncologist. 2004;9:3-13.
http://dx.doi.org/10.1634/theoncologist.9-90004-3
PMid:15459425

 

13. Scoletta M, Arduino PG, Pol R, Arata V, Silvestri S, Chiecchio A, et al. Initial experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report. J Oral Maxillofac Surg. 2011;69:456-62.
http://dx.doi.org/10.1016/j.joms.2010.07.026
PMid:21129835

 

14. Rogers S, Rahman N, Ryan D, Flint S, Healy C, Stassen LF. Guidelines for treating patients taking bisphosphonates prior to dental extractions. J Ir Dent Assoc. 2010;56:40.
PMid:20337145

 

15. Vescovi P, Merigo E, Meleti M, Manfredi M. Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment?. J Oral Maxillofac Surg. 2006;64:1460-2.
http://dx.doi.org/10.1016/j.joms.2006.05.042
PMid:16916694

 

16. Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, et al. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Photomed Laser Surg. 2008;26:37-46.
http://dx.doi.org/10.1089/pho.2007.2181
PMid:18248160

 

17. Vescovi P, Campisi G, Fusco V, Mergoni G, Manfredi M, Merigo E, et al. Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol. 2011;47:191-4.
http://dx.doi.org/10.1016/j.oraloncology.2010.11.007
PMid:21292541

 

18. Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg. 2008;66:767-75.
http://dx.doi.org/10.1016/j.joms.2007.11.035
PMid:18355603

 

19. Campisi G, Di Fede O, Musciotto A, Lo Casto A, Lo Muoio L, Fulfaro F, et al. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. Ann Oncol. 2007;18 Suppl 6:168-72.
http://dx.doi.org/10.1093/annonc/mdm250
PMid:17591816

 

20. Madrid C, Abarca M, Bouferrache K. Osteoradionecrosis: an update. Oral Oncol. 2010;46:471-4.
http://dx.doi.org/10.1016/j.oraloncology.2010.03.017
PMid:20457536

 

21. Schmidt GA, Horner KE, McDanel DL, Ross MB, Moores KG. Risks and benefits of long-term bisphosphonate therapy. Am J Health Syst Pharm. 2010;67:994-1001.
http://dx.doi.org/10.2146/ajhp090506
PMid:20516469

 

22. Wutzl A, Pohl S, Sulzbacher I, Seemann R, Lauer G, Ewers R, et al. Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws. Head Neck. 2012;34:194-200.
http://dx.doi.org/10.1002/hed.21708
PMid:21400630

 

23. Advisory Task Force on Bisphosphonates-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369-76.
http://dx.doi.org/10.1016/j.joms.2006.11.003
PMid:17307580

 

24. Kan B, Altay MA, Taşar F, Akova M. Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate. Lasers Med Sci. 2011;26:569-75.
http://dx.doi.org/10.1007/s10103-010-0816-7
PMid:20669038

 

25. Pourzarandian A, Watanabe H, Ruwanpura SM, Aoki A, Ishikawa I. Effect of low-level Er:YAG laser irradiation on cultured human gingival fibroblasts. J Periodontol. 2005;76:187-93.
http://dx.doi.org/10.1902/jop.2005.76.2.187
PMid:15974841

 

26. Guzzardella GA, Fini M, Torricelli P, Giavaresi G, Giardino R. Laser stimulation on bone defect healing: an in vitro study. Lasers Med Sci. 2002;17:216-20.
http://dx.doi.org/10.1007/s101030200031
PMid:12181636

 

27. Rabelo SB, Villaverde AB, Nicolau R, Salgado MC, Melo Mda S, Pacheco MT. Comparison between wound healing in induced diabetic and nondiabetic rats after low-level laser therapy. Photomed Laser Surg. 2006;24:474-9.
http://dx.doi.org/10.1089/pho.2006.24.474
PMid:16942427

 

28. Kucerová H, Dostálová T, Himmlova L, Bártová J, Mazánek J. Low-level laser therapy after molar extraction. J Clin Laser Med Surg. 2000;18:309-15.
PMid:11572225

 

29. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series. J Oral Maxillofac Surg. 2010;68:107-10.
http://dx.doi.org/10.1016/j.joms.2009.07.068
PMid:20006163

 

30. Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedding G, et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg. 2010;68:797-804.
http://dx.doi.org/10.1016/j.joms.2009.10.026
PMid:20307765